Sign in
4

Changes in Ownership

Cytek Biosciences, Inc. Filed Acc 0001209191-22-046948

SVP Marketing and Corp. Dev. gave up 308 shares (to pay taxes)

  • SVP Marketing and Corp. Dev. acquired 790 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Poirson Allen SVP Marketing and Corp. Dev. 2022-08-18 Option exercise +790 41,815 D
Poirson Allen SVP Marketing and Corp. Dev. 2022-08-18 Shares withheld for taxes −308 $14.06 $4,330 41,507 D
Derivatives
Poirson Allen SVP Marketing and Corp. Dev. 2022-08-18 Option exercise · Restricted Stock Units −790 10,803 D
Loading xslF345X03/doc4.xml…